Benefit of adjuvant chemoradiotherapy in patients with pathological stage III gastric cancer

BACKGROUND: For patients with locally advanced gastric cancer (LAGC) after D2 gastrectomy, the survival benefits of receiving adjuvant chemoradiotherapy versus adjuvant chemotherapy are unclear. This study aimed to compare the 5- and 7-year overall survival (OS) in the two groups and to identify whi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Manag Res
Hauptverfasser: Ma, Gui-Fen, Zhang, Hai-Ge, Liu, Juan, Chen, Yi-Xing, Xiao, Han, Wang, Xue-Fei, He, Jian, Zeng, Zhao-Chong, Sun, Jing, Liu, Tian-Shu
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove 2019
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6612289/
https://ncbi.nlm.nih.gov/pubmed/31303797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S204887
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge